Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine

pengarang

Craig Slingluff

Margaret von Mehren

Kimberly A Chianese-Bullock

diterbitkan dalam: Journal of Clinical Oncology

tanggal publikasi: 2011-06-20

bahasa: Inggris

subyek utama: multicenter clinical trial

Cites articles 45

Date

Judul

Pengarang

2010-07-01

Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines

Craig Slingluff, Margaret von Mehren, Kimberly A Chianese-Bullock
2010-08-19

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Dirk Schadendorf, Paul Lorigan, Christian H. Ottensmeier, Caroline Robert, Jedd D Wolchok, F Stephen Hodi
2009-11-10

Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial

Craig Slingluff, Kimberly A Chianese-Bullock
2009-10-05

Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation

Steven T. Piantadosi, Vered Stearns, Elizabeth Jaffee
2009-08-01

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

John Nemunaitis
2009-03-21

Adoptive cell therapy for the treatment of patients with metastatic melanoma

Steven Rosenberg
2008-09-22

Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens

Craig Slingluff, Kimberly A Chianese-Bullock
2008-06-19

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Achim A Jungbluth
2008-05-01

A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer

Kevin T Hogan, Craig Slingluff, Kimberly A Chianese-Bullock
2007-11-01

Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting

Craig Slingluff, Kimberly A Chianese-Bullock
2007-10-22

Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes

Sylvain Audia, Dominique Cathelin, Eric Solary, Bernard Bonnotte
2007-01-01

Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells

Mohamed L. Salem, Sabry A El-Naggar
2007-04-18

Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine

Maria Masucci
2005-05-09

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

Elizabeth Jaffee
2005-03-01

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells

Christopher A. Klebanoff, Steven Rosenberg
2004-11-01

Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule

Craig Slingluff, Kimberly A Chianese-Bullock
2004-09-01

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

Bruce D. Walker, Marcus Altfeld, Xu G Yu, Eric S Rosenberg, Marylyn Addo, Galit Alter, Mathias Lichterfeld, Gregory T Robbins, Eunice Pae, Alysse G Wurcel, Stanley K Mui, Daniel E Kaufmann
2004-08-07

A listing of human tumor antigens recognized by T cells: March 2004 update
2004-08-01

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma
2004-02-01

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

François Martin, Eric Solary, François Ghiringhelli, Bruno Chauffert
2003-07-01

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

Nicholas P. Restifo, Steven Rosenberg, Patrick Hwu, Suzanne L. Topalian, Sharon A Mavroukakis, Douglas J Schwartzentruber, Claudia A Seipp, Linda J Freezer
2003-11-01

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

Craig Slingluff, Kimberly A Chianese-Bullock
2002-02-01

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

Guido Ferrari, Deborah Birx, Josephine H Cox, Jeffrey R Currier
2001-10-01

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes

Victor H Engelhard
2001-08-01

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

Charles M. Balch, Kelly M. McMasters
2001-05-01

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
2001-02-01

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
2001-11-16

Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model
2000-03-01

Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer

Giovanna Schiavoni, Fabrizio Mattei, Stefano M. Santini
2000-05-01

Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide

R. Daniel Bonfil
1999-08-01

Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
1999-07-01

A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL

Jay A Berzofsky

Artikel - wd:Q30425914

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut